Benzinga's Top Initiations

Analysts at Mizuho initiated coverage on Biogen Inc (NASDAQ: BIIB) with a Neutral rating. The price target for Biogen is set to $290. Biogen shares closed at $295.62 on Monday.
Jefferies initiated coverage on BioScrip Inc (NASDAQ: BIOS) with a Buy rating. BioScrip shares closed at $2.61 on Monday.
Analysts at Piper Jaffray initiated coverage of Mammoth Energy Services Inc (NASDAQ: TUSK) with an Overweight rating. Mammoth Energy shares closed at $13.61 on Monday.
Analysts at JP Morgan initiated coverage of Adient PLC (NYSE: ADNT) with a Neutral rating. The price target for Adient is set to $55. Adient shares closed at $44.60 on Monday.
Analysts at Aegis Capital initiated coverage on Nektar Therapeutics (NASDAQ: NKTR) with a Buy rating. The price target for Nektar Therapeutics is set to $21. Nektar Therapeutics shares closed at $12.80 on Monday.
Mizuho initiated coverage on Amgen, Inc. (NASDAQ: AMGN) with a Buy rating. The price target for Amgen is set to $164. Amgen shares closed at $139.21 on Monday.
Analysts at Deutsche Bank initiated coverage on Microsemi Corporation (NASDAQ: MSCC) with a Buy rating. The price target for Microsemi is set to $60. Microsemi shares closed at $47.84 on Monday.
Analysts at Imperial Capital initiated coverage on Newcastle Investment Corp. (NYSE: NCT) with an In-Line rating. The price target for Newcastle Investment is set to $4.50. Newcastle Investment shares closed at $4.54 on Monday.
Analysts at BMO Capital initiated coverage on Sociedad Quimica y Minera de Chile (ADR) (NYSE: SQM) with a Market Perform rating. The price target for Sociedad Quimica y Minera de Chile is set to $30. Sociedad Quimica y Minera de Chile shares closed at $29.07 on Monday.
Mizuho initiated coverage on Celgene Corporation (NASDAQ: CELG) with a Buy rating. The price target for Celgene is set to $130. Celgene shares closed at $107.49 on Monday.

Market News and Data brought to you by Benzinga APIs

To add Benzinga News as your preferred source on Google, click here.

Analysts at Mizuho initiated coverage on Biogen Inc (NASDAQ: BIIB) with a Neutral rating. The price target for Biogen is set to $290. Biogen shares closed at $295.62 on Monday.
Jefferies initiated coverage on BioScrip Inc (NASDAQ: BIOS) with a Buy rating. BioScrip shares closed at $2.61 on Monday.
Analysts at Piper Jaffray initiated coverage of Mammoth Energy Services Inc (NASDAQ: TUSK) with an Overweight rating. Mammoth Energy shares closed at $13.61 on Monday.
Analysts at JP Morgan initiated coverage of Adient PLC (NYSE: ADNT) with a Neutral rating. The price target for Adient is set to $55. Adient shares closed at $44.60 on Monday.
Analysts at Aegis Capital initiated coverage on Nektar Therapeutics (NASDAQ: NKTR) with a Buy rating. The price target for Nektar Therapeutics is set to $21. Nektar Therapeutics shares closed at $12.80 on Monday.
Mizuho initiated coverage on Amgen, Inc. (NASDAQ: AMGN) with a Buy rating. The price target for Amgen is set to $164. Amgen shares closed at $139.21 on Monday.
Analysts at Deutsche Bank initiated coverage on Microsemi Corporation (NASDAQ: MSCC) with a Buy rating. The price target for Microsemi is set to $60. Microsemi shares closed at $47.84 on Monday.
Analysts at Imperial Capital initiated coverage on Newcastle Investment Corp. (NYSE: NCT) with an In-Line rating. The price target for Newcastle Investment is set to $4.50. Newcastle Investment shares closed at $4.54 on Monday.
Analysts at BMO Capital initiated coverage on Sociedad Quimica y Minera de Chile (ADR) (NYSE: SQM) with a Market Perform rating. The price target for Sociedad Quimica y Minera de Chile is set to $30. Sociedad Quimica y Minera de Chile shares closed at $29.07 on Monday.
Mizuho initiated coverage on Celgene Corporation (NASDAQ: CELG) with a Buy rating. The price target for Celgene is set to $130. Celgene shares closed at $107.49 on Monday.